Super easy and attainable
A 2023 systematic review in Obesity Reviews examined non-prescription transdermal patches marketed for weight reduction and found no evidence supporting their efficacy
AbbVies strategy assumes that generic manufacturers will not find it economically rational to challenge each patent sequentially, given the years of litigation required and the resulting uncertainty about exactly when entry can occur
Eight percent weight loss, halved liver fat, lower triglycerides, and reduced appetite cannot be explained by GIP alone
Nutrient timing and meal structure When you can only eat two or three meals a day because your appetite has been crushed by a triple agonist, every meal needs to count
is supported by operating grants from the CIHR, a Banting and Best Diabetes CentreNovo Nordisk Chair in Incretin Biology and a Sinai HealthNovo Nordisk Foundation Fund in Regulatory Peptides